Cargando…
Fabry pedigree analysis: A successful program for targeted genetic approach
BACKGROUND: Fabry disease (FD) is an X‐linked disorder of glycosphingolipid catabolism caused by a deficiency of the lysosomal enzyme alpha‐galactosidase A (GLA). FD is still an underdiagnosed disorder worldwide. Moreover, there is delay between symptom onset and Fabry diagnosis of at least 10 years...
Autores principales: | Rozenfeld, Paula A., Masllorens, Francisca M., Roa, Norma, Rodriguez, Fernanda, Bonnano, Mariela, Yvorra, Carolina, Ceci, Romina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625140/ https://www.ncbi.nlm.nih.gov/pubmed/31169365 http://dx.doi.org/10.1002/mgg3.794 |
Ejemplares similares
-
Efficacy of pentosan polysulfate in in vitro models of lysosomal storage disorders: Fabry and Gaucher Disease
por: Crivaro, Andrea N., et al.
Publicado: (2019) -
Effect of COVID19 pandemic on Argentinian Fabry and Gaucher patients
por: Rozenfeld, Paula A., et al.
Publicado: (2022) -
Clinical evaluation, accurate diagnosis and treatment of four pedigrees with Fabry's disease
por: Gou, Peng, et al.
Publicado: (2023) -
Parkinson’s Disease and Fabry Disease: Clinical, Biochemical and Neuroimaging Analysis of Three Pedigrees
por: Gago, Miguel Fernandes, et al.
Publicado: (2020) -
COVID-19 Coinfection with Mycobacterium abscessus in a Patient with Multiple Myeloma
por: Rodriguez, Jose A., et al.
Publicado: (2021)